sellModerate
Biotech Growth N V sold $12M of EPIX
owner at ESSA Pharma Inc.. 7,879,583 shares at an average of $1.53, traded Nov 1, 2024, filed Nov 5, 2024.
Warning score
57Value
$12M
7,879,583 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +25Trade size$12.0M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-121206, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | SOpen-market sale Common Shares | -2,000,000 | $1.53 | $3.1M | 5,879,583 | Nov 5, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Shares | -2,000,000 | $1.53 | $3.1M | 3,879,583 | Nov 5, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Shares | -2,000,000 | $1.53 | $3.1M | 1,879,583 | Nov 5, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Shares | -1,879,583 | $1.51 | $2.8M | 0 | Nov 5, 2024 |
Related signals
Other insiders at ESSA Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | EPIXsell ESSA Pharma Inc. | Bvf Partners L P/il owner | $293 156 shares | -0% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $4,185 694 shares | -8% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $4,164 694 shares | -8% | |
| 5Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $13k 2,082 shares | -19% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $4,823 694 shares | -6% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $5,510 694 shares | -5% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $6,232 694 shares | -5% | |
| 26Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $749k 72,782 shares | -85% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $11k 1,194 shares | -9% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $17k 1,718 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.